Toxina botulínica A para disminuir la espasticidad tras el accidente cerebrovascular

Sandra Martínez Pizarro

Texto completo:



Kerstens HCJW, Satink T, Nijkrake MJ, De Swart BJM, Nijhuis-van der Sanden MWG, Van der Wees, et al. Experienced consequences of spasticity and effects of botulinum toxin injections: a qualitative study amongst patients with disabling spasticity after stroke. Disabil Rehabil. [internet] 2020 [citado 20 Abril 2020]; 7: 1-8. Disponible en:

Wissel J, Fheodoroff K, Hoonhorst M, Müngersdorf M, Gallien P, Meier N, et al. Effectiveness of AbobotulinumtoxinA in Post-stroke Upper Limb Spasticity in Relation to Timing of Treatment. Front Neurol. [internet] 2020 [citado 20 Abril 2020]; 11: 104.

Abo M, Shigematsu T, Hara H, Matsuda Y, Nimura A, Yamashita Y, et al. Efficacy and Safety of OnabotulinumtoxinA 400 Units in Patients with Post-Stroke Upper Limb Spasticity: Final Report of a Randomized, Double-Blind, Placebo-Controlled Trial with an Open-Label Extension Phase. Toxins (Basel). [internet] 2020 [citado 20 Abril 2020]; 12(2): e127.

Lazzaro C, Baricich A, Picelli A, Caglioni PM, Ratti M, Santamato A. AbobotulinumtoxinA and rehabilitation vs rehabilitation alone in post-stroke spasticity: A cost-utility analysis. J Rehabil Med. [internet] 2020 [citado 20 Abril 2020]; 52(2). pii: jrm00016.

López de Munain L, Valls-Solé J, Garcia Pascual I, Maisonobe P. Botulinum Toxin Type A Improves Function According to Goal Attainment in Adults with Poststroke Lower Limb Spasticity in Real Life Practice. Eur Neurol. [internet] 2019 [citado 20 Abril 2020]; 82(1-3): 1-8.

Enlaces refback

  • No hay ningún enlace refback.

Copyright (c) 2020 16 de Abril

Licencia de Creative Commons
Esta obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional.